Last reviewed · How we verify
NCT06095193
The Effect of Education on Vaginal Effects of Menopausal Women
NA trial testing menopause education in Menopause in 102 participants. Status unknown.
30 December 2023
Quick facts
| Lead sponsor | Gaziantep Islam Science and Technology University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 102 |
| Start date | 25 October 2023 |
| Primary completion | 30 December 2023 |
| Estimated completion | 28 February 2024 |
Drugs / interventions tested
- menopause education
Conditions studied
- Menopause — all drugs for Menopause →
- Aging — all drugs for Aging →
- Failure of Genital Response — all drugs for Failure of Genital Response →
Sponsor
Gaziantep Islam Science and Technology University
Who can join
Adults 45 to 65, female only, with Menopause or Aging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of our study is to examine the effect of education applied to women in menopause on the daily effects of vaginal aging, avoidance of sexuality and sexual stress. It is a pretest-posttest randomized controlled experimental study. The universe of the research; It consisted of menopausal women over the age of 45 who attended courses at Özgecan Cultural Center and Binevler Social Facility in Gaziantep. The sample of the research consisted of 102 people determined by the GPower method and determined by simple random method among all women who volunteered to participate in the study. Introductory Information Form, Daily Effect of Vaginal Aging Scale, Sexuality Avoidance Decision Balance Scale and Sexuality Avoidance Self-Efficacy Scale, Female Sexual Distress Scale were used to collect the research data. . The data will be collected face to face with the form prepared by the researchers after mass announcements and explanations are made to the women.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06095193
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Menopause
Currently open trials in the same condition.
- NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
- NCT07135232 — The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. · NA · recruiting
- NCT06975111 — Focusing on the Menopausal Transition to Improve Mid-Life Women's Health · Phase 2, PHASE3 · recruiting
- NCT07393672 — Effects of Hemp-Derived Cannabinoids on Menopause Symptoms · Phase 2 · recruiting
- NCT07412093 — The Effect of Progressive Relaxation Exercises and Planned Education on Menopausal Symptoms, Perceived Stress, and Anxie · NA · active not recruiting
Other Gaziantep Islam Science and Technology University trials
Trials by the same sponsor.
- NCT07155538 — Bed Bridge Test in Acute Stroke Patients · not yet recruiting
- NCT07155161 — Backward Walking and Related Factors in Individuals With Stroke · not yet recruiting
- NCT07150078 — Dual Task and Attention Deficit and Hyperactivity Disorder · completed
- NCT07478562 — Thoracolumbar Fascia · NA · completed
- NCT06785155 — AI Chatbot-Based Learning on Dry Eye and Eye Strain Knowledge · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06095193 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gaziantep Islam Science and Technology University
- Last refreshed: 23 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06095193.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing